The differences in the responsiveness among the tested cell lines, including complete lack of ERE activity (Fig. S1), were not correlated to expression levels of ESR1/ERBB2/PGR, molecular classification, or important gene mutations in BC (Fig. S1). Here, ERBB2 is linked to breast cancer.